Related references
Note: Only part of the references are listed.The anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignancies
Y-C Linn et al.
BONE MARROW TRANSPLANTATION (2012)
Mathematical approach for the optimal expansion of erythroid progenitors in monolayer culture
Varun Lahoti et al.
JOURNAL OF BIOTECHNOLOGY (2012)
Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)
C. Hontscha et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
Dario Sangiolo
JOURNAL OF CANCER (2011)
Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients
Jing-Ting Jiang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes
Marta Franceschetti et al.
EXPERIMENTAL HEMATOLOGY (2009)
Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation
D. Sangiolo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell
Yeh C. Linn et al.
IMMUNOLOGY (2009)
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers
Dario Sangiolo et al.
INTERNATIONAL IMMUNOLOGY (2008)
Assessment of PLSDA cross validation
Johan A. Westerhuis et al.
METABOLOMICS (2008)
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study
Martino Introna et al.
HAEMATOLOGICA (2007)
Kinetic analysis of the ex vivo expansion of human hematopoietic stem/progenitor cells
R Gonçalves et al.
BIOTECHNOLOGY LETTERS (2006)
A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma
T Leemhuis et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Orthogonal projections to latent structures (O-PLS)
J Trygg et al.
JOURNAL OF CHEMOMETRICS (2002)
Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production
J Baker et al.
BLOOD (2001)
Share Paper
